Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
11
Number of overlapping holdings
3.4%
% of FHLC's 349 holdings also in OZEM
45.8%
% of OZEM's 25 holdings also in FHLC
Overlap by Weight
Sector Drift (FHLC minus OZEM)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in FHLC |
Weight in OZEM |
Overlap | |
|---|---|---|---|---|
 |
ELI LILLY & CO | 11.3% | 17.7% | 11.3% |
|
AMGEN INC | 2.8% | 4.7% | 2.8% |
|
PFIZER INC | 2.4% | 3.7% | 2.4% |
|
GILEAD SCIENCES INC | 2.3% | 2.7% | 2.3% |
|
REGENERON PHARMACEUTICALS | 1.2% | 2.4% | 1.2% |
Position Highlights (Non-Overlapping Exposures)
FHLC Overweight Relative to OZEM
|
UNITEDHEALTH GROUP INC | 7.3% |
|
JOHNSON & JOHNSON | 6.4% |
|
ABBVIE INC | 6.1% |
|
MERCK & CO. INC. | 3.8% |
|
ABBOTT LABORATORIES | 3.8% |
|
THERMO FISHER SCIENTIFIC INC | 3.3% |
|
INTUITIVE SURGICAL INC | 3.0% |
|
BOSTON SCIENTIFIC CORP | 2.3% |
|
DANAHER CORP | 2.2% |
|
STRYKER CORP | 2.1% |
FHLC Underweight Relative to OZEM
 |
NOVO-NORDISK A/S-SPONS ADR | -12.7% |
 |
ROCHE HOLDING LTD | -6.5% |
|
ELI LILLY & CO | -6.4% |
 |
ASTRAZENECA PLC-SPONS ADR | -5.2% |
 |
INNOVENT BIOLOGICS, INC. | -4.9% |
 |
CHUGAI PHARMACEUTICAL CO LTD | -4.8% |
|
ZEALAND PHARMA A/S | -3.9% |
 |
HANMI PHARM CO LTD | -2.9% |
 |
THE UNITED LABORATORIES INTE | -2.7% |
|
TAKEDA PHARMACEUTICAL CO. LTD. SPONS | -2.4% |